CYP75B1 Antibody

Shipped with Ice Packs
In Stock

Description

Key Features of CYP75B1 Antibody

ParameterDescription
TargetCYP75B1 enzyme (543 amino acids, ER-localized)
Antibody TypePolyclonal (raised against synthetic peptides or recombinant proteins)
ApplicationsWestern blotting, ELISA, immunoprecipitation, subcellular localization studies
SpecificityHigh specificity to CYP75B1, distinguishing it from related P450 isoforms (e.g., CYP73A5, CYP98A3)

Production and Validation Methods

CYP75B1 antibodies are generated using methodologies analogous to those for other P450 enzymes:

Recombinant Production

  1. Cloning and Expression:

    • Full-length CYP75B1 or peptide sequences are cloned into expression vectors (e.g., pcDNA™) and expressed in heterologous systems (e.g., E. coli, mammalian cells) .

    • Tags (e.g., His-tag, GST) are added for purification .

  2. Antibody Generation:

    • Polyclonal antibodies are raised in rabbits or mice using purified recombinant CYP75B1 or synthetic peptides .

    • Hybridoma or phage display technologies may yield monoclonal antibodies for higher specificity .

Validation Techniques

MethodPurpose
Western BlottingDetects CYP75B1 in plant lysates; confirms antibody specificity
ELISAQuantifies CYP75B1 levels in tissues or cell cultures
ImmunoprecipitationIsolates CYP75B1 for enzymatic activity assays or interaction studies

Applications in Research

CYP75B1 antibodies are pivotal for elucidating the enzyme’s role in plant metabolism and disease resistance.

Functional Studies

  1. Flavonoid Biosynthesis:

    • CYP75B1 catalyzes hydroxylation of flavonoids (e.g., converting dihydroflavonols to flavonols), influencing anthocyanin accumulation . Antibodies enable tracking of CYP75B1 expression during developmental stages or stress responses.

  2. Subcellular Localization:

    • Immunofluorescence or GFP-tagged CYP75B1 combined with antibody probing confirms endoplasmic reticulum localization .

Pathway Regulation

  • Transcriptome Profiling: Correlates CYP75B1 mRNA levels with metabolite profiles (e.g., flavonoid content in Citrus aurantium) .

  • Protein-Protein Interactions: Identifies partners (e.g., chaperones, electron transfer partners) via co-immunoprecipitation .

Comparative Analysis with Related P450 Antibodies

CYP75B1 antibodies share methodologies with those for other P450 enzymes (e.g., CYP1B1, CYP2E1), but differ in target specificity.

EnzymeAntibody ApplicationKey Findings
CYP1B1Detection in tumor cells, immunosensor development Overexpression in breast cancer; scFv-based biosensors achieve nM sensitivity
CYP2E1Autoantibody profiling in occupational diseases Elevated IgG levels correlate with trichloroethylene exposure
CYP75B1Flavonoid pathway analysis, stress response studiesCritical for anthocyanin synthesis; regulated by tissue-specific factors

Challenges and Future Directions

  1. Specificity Challenges:

    • CYP75B1 shares structural homology with other P450s (e.g., CYP73A5, CYP98A3), requiring antibodies against unique epitopes (e.g., C-terminal regions) .

  2. Emerging Technologies:

    • Recombinant scFvs: Miniaturized antibodies for intracellular or in vivo imaging .

    • CRISPR-Based Editing: Combining antibody detection with gene knockout to study CYP75B1’s role in phenotypes .

References and Supporting Data

  1. Structural Insights: Molecular modeling of CYP75B1 reveals conserved active-site architectures, guiding antibody design .

  2. Validation Protocols: Western blotting and ELISA methods from CYP1B1 and CYP2E1 studies provide templates .

  3. Plant Metabolomics: Transcriptome and HPLC data link CYP75B1 expression to flavonoid accumulation in Citrus aurantium .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
CYP75B1 antibody; F3'H antibody; TT7 antibody; At5g07990 antibody; F13G24.190 antibody; Flavonoid 3'-monooxygenase antibody; EC 1.14.14.82 antibody; Cytochrome P450 75B1 antibody; Flavonoid 3'-hydroxylase antibody; AtF3'H antibody; Protein TRANSPARENT TESTA 7 antibody
Target Names
CYP75B1
Uniprot No.

Target Background

Function
This antibody targets CYP75B1, an enzyme that catalyzes the 3'-hydroxylation of the flavonoid B-ring, converting it to the 3',4'-hydroxylated state. Specifically, it facilitates the conversion of naringenin to eriodictyol and dihydrokaempferol to dihydroquercetin.
Database Links

KEGG: ath:AT5G07990

STRING: 3702.AT5G07990.1

UniGene: At.12059

Protein Families
Cytochrome P450 family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass type III membrane protein.
Tissue Specificity
High expression in siliques and to a lower extent in stems, flowers and senescing leaves.

Q&A

What is CYP75B1 and what role does it play in plant systems?

CYP75B1 is a flavonoid 3'-monooxygenase gene belonging to the cytochrome P450 family that plays a significant role in plant stress responses, particularly under waterlogging conditions. Studies have shown that CYP75B1 variants affect normal development of stressed young plants due to altered antioxidant properties, which can lead to hampered cell differentiation . This gene is involved in the biosynthesis of flavonoids, which serve as important secondary metabolites in plants that contribute to various physiological functions including stress tolerance, pigmentation, and defense mechanisms.

The protein encoded by CYP75B1 catalyzes the hydroxylation of the 3'-position of the B-ring of flavonoids, a critical step in the biosynthesis pathway of anthocyanins and other flavonoid compounds. Understanding this enzyme's function is essential for researchers studying plant biochemistry, stress physiology, and genetic improvement programs focused on enhancing stress tolerance traits.

What are the standard methods for detecting CYP75B1 using antibodies?

Several standard immunological techniques can be employed for detecting CYP75B1 in plant tissues using specific antibodies:

  • Western Blotting: This remains the gold standard for CYP75B1 protein detection and semi-quantification. Typically, plant tissue is homogenized in an appropriate buffer containing protease inhibitors, followed by protein extraction, SDS-PAGE separation, and transfer to a membrane. CYP75B1-specific primary antibodies are then applied, followed by secondary antibody detection using chemiluminescence or fluorescence-based systems.

  • Immunohistochemistry (IHC)/Immunofluorescence (IF): These techniques allow for the localization of CYP75B1 within specific tissues and subcellular compartments. Fixed tissue sections are incubated with CYP75B1 antibodies followed by appropriate secondary antibodies conjugated to enzymes (for IHC) or fluorophores (for IF).

  • Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative analysis of CYP75B1 protein levels, ELISA provides a high-throughput approach. Both sandwich and competitive ELISA formats can be adapted for CYP75B1 detection.

  • Immunoprecipitation (IP): This technique enables isolation of CYP75B1 from complex protein mixtures for downstream applications such as activity assays or mass spectrometry analysis.

When implementing these methods, researchers should carefully optimize antibody dilutions, blocking conditions, and washing protocols to ensure specific detection while minimizing background signals.

How do CYP75B1 antibodies contribute to understanding plant stress responses?

CYP75B1 antibodies serve as valuable tools for investigating the relationship between flavonoid biosynthesis and stress tolerance in plants. Through immunodetection approaches, researchers can:

  • Monitor expression patterns: Track changes in CYP75B1 protein levels in response to various stressors, including waterlogging, drought, temperature extremes, and pathogen attacks.

  • Compare genotypic differences: Assess CYP75B1 expression across different plant varieties with varying stress tolerance levels. Research has demonstrated that waterlogging-tolerant maize lines are heterozygous for CYP75B1, suggesting a potential correlation between specific genetic variants and stress adaptation .

  • Establish spatial distribution: Determine tissue-specific localization of CYP75B1 to understand which plant organs contribute most significantly to stress-responsive flavonoid production.

  • Temporal dynamics: Evaluate time-dependent changes in CYP75B1 abundance during stress exposure and recovery phases.

By combining antibody-based detection methods with physiological measurements and genetic analyses, researchers can establish causal relationships between CYP75B1 function and stress resilience mechanisms in plants.

What methodological approaches are recommended for investigating CYP75B1 involvement in waterlogging tolerance?

Based on current research findings, several methodological approaches are recommended for investigating CYP75B1's role in waterlogging tolerance:

  • Comparative proteomics with immunoprecipitation: Using CYP75B1 antibodies for immunoprecipitation followed by mass spectrometry analysis can reveal protein interaction partners that change under waterlogging conditions. This approach helps identify molecular networks involving CYP75B1.

  • Co-localization studies: Dual immunofluorescence with antibodies against CYP75B1 and other proteins involved in flavonoid biosynthesis or stress response pathways can reveal spatial relationships during waterlogging stress.

  • Enzyme activity correlation: Combine antibody-based quantification of CYP75B1 protein levels with direct measurement of flavonoid 3'-monooxygenase enzymatic activity to establish structure-function relationships.

  • Genotype-phenotype association analysis: Compare CYP75B1 protein expression levels across plant lines with known SNP variations in the CYP75B1 gene. Studies have identified specific putative SNPs from quantitative trait loci (QTLs) involved in waterlogging tolerance that overlap with the flavonoid 3'-monooxygenase gene (CYP75B1) .

  • Time-course experiments: Design experiments that sample at multiple timepoints during waterlogging stress to capture dynamic changes in CYP75B1 expression and correlate these with physiological parameters and metabolite profiles.

When implementing these approaches, researchers should maintain appropriate controls and consider the heterozygosity of CYP75B1 in waterlogging-tolerant plant lines as observed in previous studies .

How can cross-reactivity issues with CYP75B1 antibodies be addressed in experimental design?

Cross-reactivity poses a significant challenge when working with antibodies against CYP75B1, particularly due to the high sequence similarity among cytochrome P450 family members. To address this issue, researchers can implement several strategies:

  • Antibody validation protocol:

    • Perform Western blot analysis using recombinant CYP75B1 protein as a positive control

    • Include knockout/knockdown plant tissues as negative controls

    • Test against closely related P450 proteins to assess cross-reactivity profiles

    • Validate with multiple antibodies targeting different epitopes of CYP75B1

  • Pre-absorption controls: Pre-incubate the antibody with purified CYP75B1 antigen before immunodetection experiments to confirm specificity.

  • Epitope selection: When developing or selecting antibodies, target unique regions of CYP75B1 that have minimal sequence homology with other cytochrome P450 enzymes.

  • Complementary approaches: Supplement antibody-based detection with orthogonal methods such as:

    • Targeted mass spectrometry for peptide-specific identification

    • Activity-based protein profiling using substrate analogs

    • Correlation with transcript levels via RT-qPCR

  • Species-specific considerations: Assess potential cross-reactivity issues when using antibodies developed against CYP75B1 from one plant species to detect orthologs in other species.

By implementing these measures, researchers can substantially reduce false-positive results and increase confidence in their experimental findings regarding CYP75B1 expression and function.

What techniques can be combined with CYP75B1 immunodetection to gain deeper insights into protein function?

To gain comprehensive insights into CYP75B1 function, researchers should consider integrating multiple techniques with immunodetection approaches:

  • Chromatin Immunoprecipitation (ChIP) analysis: Using antibodies against transcription factors potentially regulating CYP75B1 expression can reveal regulatory mechanisms controlling this gene under different stress conditions.

  • Proximity ligation assays (PLA): This technique allows visualization of protein-protein interactions involving CYP75B1 in situ, providing spatial information about complex formation during stress responses.

  • Metabolomic profiling: Correlating CYP75B1 protein levels with changes in flavonoid profiles using LC-MS/MS can establish direct connections between enzyme abundance and metabolic outputs.

  • CRISPR-based genome editing: Creating targeted mutations in CYP75B1 genes followed by antibody-based phenotyping can validate functional relationships between specific genetic variants and protein function.

  • Super-resolution microscopy: Combined with immunofluorescence, techniques like STORM or PALM can reveal subcellular localization patterns of CYP75B1 with nanometer precision.

  • Protein turnover analysis: Pulse-chase experiments with immunoprecipitation can determine CYP75B1 stability under different conditions, providing insights into post-translational regulatory mechanisms.

  • Single-cell proteomics: Emerging techniques combining immunolabeling with single-cell analysis can reveal cell-type-specific expression patterns of CYP75B1 within complex tissues.

This integrated approach provides a comprehensive understanding of CYP75B1 function beyond what any single technique can reveal.

What are the optimal sample preparation protocols for CYP75B1 antibody-based experiments?

Effective sample preparation is crucial for successful CYP75B1 antibody-based experiments. The following protocol recommendations address the specific challenges associated with membrane-bound cytochrome P450 enzymes:

Plant Tissue Protein Extraction for CYP75B1 Immunodetection:

  • Tissue collection and preservation:

    • Harvest plant tissues quickly and flash-freeze in liquid nitrogen

    • Store at -80°C until processing

    • Avoid repeated freeze-thaw cycles to prevent protein degradation

  • Homogenization buffer selection:

    • Use buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100 or 0.5% CHAPS

    • Include protease inhibitor cocktail (PMSF, leupeptin, aprotinin)

    • Add 1-2 mM DTT to maintain reducing conditions

    • Consider including 10% glycerol for protein stabilization

  • Membrane protein solubilization:

    • Since CYP75B1 is a membrane-associated protein, gentle detergent extraction is critical

    • Optimize detergent concentration to maintain native conformation while ensuring sufficient extraction

    • Consider using a two-step extraction process: initial extraction without detergent followed by membrane protein solubilization

  • Post-extraction processing:

    • Centrifuge homogenate at 10,000 × g for 15 minutes to remove cellular debris

    • For membrane-enriched fractions, perform ultracentrifugation at 100,000 × g for 1 hour

    • Determine protein concentration using Bradford or BCA assays

    • Aliquot samples to avoid repeated freeze-thaw cycles

This optimized protocol ensures maximal extraction and preservation of CYP75B1 for subsequent immunodetection, while minimizing interference from other cellular components.

How should researchers approach CYP75B1 antibody validation in different plant species?

Validating CYP75B1 antibodies across different plant species requires a systematic approach to account for potential sequence variations and ensure reliable results:

  • Sequence analysis and epitope conservation assessment:

    • Perform multiple sequence alignment of CYP75B1 proteins from target species

    • Identify conserved and variable regions to predict cross-reactivity

    • If antibody epitope information is available, assess its conservation across species

    • Calculate percent identity and similarity scores to estimate cross-reactivity potential

  • Graduated validation hierarchy:

    • Start with positive control species (the species against which antibody was raised)

    • Move to closely related species with high sequence identity

    • Proceed to more distantly related species with appropriate controls

    • For each species, implement the following validation steps:

  • Specificity controls:

    • Western blot analysis with predicted molecular weight verification

    • Inclusion of negative controls (knockout/knockdown if available)

    • Competitive binding assays with purified or recombinant antigen

    • Serial dilution tests to assess signal linearity

  • Functionality verification:

    • Correlate antibody signals with expected physiological or developmental patterns

    • Compare antibody detection with transcript levels (noting that these may not always correlate)

    • Confirm subcellular localization matches predicted patterns for CYP75B1

  • Documentation and transparency:

    • Record detailed validation results for each species

    • Report both successful and unsuccessful cross-reactivity to benefit the research community

    • Provide validation data in publications and repositories

This structured approach ensures reliable application of CYP75B1 antibodies across different plant species and promotes reproducible research in the field.

What are the critical parameters to consider when designing experiments to study CYP75B1 expression under stress conditions?

When designing experiments to study CYP75B1 expression under stress conditions, several critical parameters must be carefully controlled:

  • Stress application standardization:

    • Define precise parameters for stress treatments (e.g., soil moisture content for waterlogging studies)

    • Control stress intensity and duration with appropriate instrumentation

    • Implement gradual stress application when relevant to mimic natural conditions

    • Record environmental parameters throughout the experiment

  • Developmental stage considerations:

    • Select consistent developmental stages for sampling

    • Document phenological parameters at treatment initiation

    • Consider age-dependent responses in experimental design

    • Include multiple developmental stages when relevant to research questions

  • Tissue-specific sampling strategy:

    • Implement precise tissue collection protocols

    • Consider tissue-specific responses when selecting sampling sites

    • Account for potential gradient effects within organs

    • Use microdissection techniques for high-resolution studies when appropriate

  • Temporal dynamics assessment:

    • Design appropriate time-course sampling schedules

    • Include both early and late response timepoints

    • Consider diurnal variations in CYP75B1 expression

    • Include recovery phase monitoring when relevant

  • Genotype selection considerations:

    • Include genotypes with known CYP75B1 variants

    • Consider using waterlogging-tolerant lines known to be heterozygous for CYP75B1

    • Include susceptible genotypes as comparative controls

    • When possible, include near-isogenic lines differing in CYP75B1 alleles

  • Replicate planning:

    • Implement sufficient biological replicates (minimum n=3, preferably n≥5)

    • Include technical replicates for immunodetection methods

    • Consider statistical power analysis for sample size determination

    • Plan for potential sample loss during processing

  • Control treatments:

    • Include unstressed controls matched for all other conditions

    • Consider including positive controls (treatments known to affect CYP75B1)

    • Implement mock treatments that mimic handling effects

    • Include appropriate antibody controls in immunodetection procedures

Careful attention to these parameters ensures generation of reliable and reproducible data on CYP75B1 expression under stress conditions.

How can researchers quantitatively analyze CYP75B1 immunodetection results?

  • Western blot quantification protocol:

    • Use high-quality image acquisition systems with linear dynamic range

    • Include calibration standards on each blot (recombinant protein series)

    • Normalize target signals to appropriate loading controls

    • Apply background subtraction using adjacent areas

    • Analyze band intensity using software tools (ImageJ, Image Lab, etc.)

    • Report relative quantities rather than absolute values

    • Present full blot images in publications or supplementary materials

  • Immunohistochemistry quantification approaches:

    • Employ digital image analysis with consistent exposure settings

    • Establish objective thresholding criteria for positive signal detection

    • Use advanced algorithms for colocalization analysis when applicable

    • Implement unbiased stereological approaches for tissue-wide quantification

    • Report signal intensity along with spatial distribution patterns

  • ELISA data analysis:

    • Generate standard curves using recombinant CYP75B1 when available

    • Apply appropriate curve-fitting models (4-parameter logistic regression)

    • Calculate inter- and intra-assay coefficients of variation

    • Determine lower limit of detection and quantification

    • Report results with confidence intervals

  • Statistical analysis considerations:

    • Test data for normality before selecting parametric/non-parametric tests

    • Apply appropriate statistical tests based on experimental design

    • Consider multiple testing corrections for complex experiments

    • Report effect sizes alongside p-values

    • Present data with appropriate visualization (box plots, scatter plots)

By implementing these quantitative approaches, researchers can extract maximum value from CYP75B1 immunodetection experiments and facilitate meaningful comparisons across different studies.

What strategies help resolve contradictory results in CYP75B1 research using antibody-based methods?

When faced with contradictory results in CYP75B1 research using antibody-based methods, researchers should implement a systematic troubleshooting and reconciliation strategy:

This systematic approach not only helps resolve contradictions but also advances methodological standards in the field of CYP75B1 research.

How can CYP75B1 antibody studies be integrated with genetic and genomic data?

Integrating CYP75B1 antibody studies with genetic and genomic data creates a powerful multi-omics approach that provides comprehensive insights into CYP75B1 function:

  • Genotype-protein expression correlation analysis:

    • Measure CYP75B1 protein levels across genotypes with known sequence variations

    • Correlate specific SNPs with protein abundance and localization patterns

    • Focus on waterlogging-related SNPs that overlap with the CYP75B1 gene

    • Analyze heterozygous vs. homozygous states and their impact on protein expression

  • eQTL-pQTL integration framework:

    • Identify expression quantitative trait loci (eQTLs) affecting CYP75B1

    • Determine protein quantitative trait loci (pQTLs) using antibody-based quantification

    • Compare eQTL and pQTL patterns to identify post-transcriptional regulation

    • Map regulatory networks controlling CYP75B1 expression

  • CRISPR-based functional validation pipeline:

    • Design CRISPR-Cas9 edits targeting specific CYP75B1 domains

    • Use antibodies to assess resulting protein expression and localization

    • Correlate protein changes with phenotypic effects

    • Implement allelic replacement to test specific variants

  • Epigenetic regulation analysis:

    • Correlate chromatin modifications at the CYP75B1 locus with protein levels

    • Assess DNA methylation patterns in relation to protein expression

    • Investigate histone modifications using ChIP-seq approaches

    • Study the impact of stress conditions on epigenetic marks and CYP75B1 expression

  • Ancestral protein reconstruction:

    • Use phylogenetic analysis to identify ancestral CYP75B1 sequences

    • Express reconstructed proteins in heterologous systems

    • Compare antibody reactivity and function between ancestral and extant proteins

    • Trace evolutionary changes in protein structure and function

  • Multi-omics data integration:

    • Implement computational frameworks for integrating protein, transcript, and genetic data

    • Use network analysis to position CYP75B1 in regulatory and metabolic networks

    • Apply machine learning approaches to identify predictive features of CYP75B1 function

    • Develop visualization tools for multi-dimensional data representation

This integrated approach provides a comprehensive understanding of CYP75B1 from genetic variation to protein function and phenotypic outcomes.

What emerging technologies will enhance CYP75B1 antibody-based research?

Several cutting-edge technologies are poised to revolutionize CYP75B1 antibody-based research in the coming years:

  • Single-cell proteomics applications:

    • Implementation of mass cytometry (CyTOF) with CYP75B1 antibodies

    • Development of single-cell Western blotting techniques

    • Adaptation of proximity extension assays for single-cell protein quantification

    • Integration with single-cell transcriptomics for multi-omic profiling

  • Advanced microscopy approaches:

    • Super-resolution microscopy for nanoscale localization of CYP75B1

    • Expansion microscopy to physically enlarge samples for enhanced resolution

    • Light-sheet microscopy for 3D imaging of entire plant organs

    • Correlative light and electron microscopy for ultrastructural context

  • Protein dynamics visualization:

    • FRAP (Fluorescence Recovery After Photobleaching) with fluorescent antibodies

    • Development of intrabodies for live-cell tracking of CYP75B1

    • Photoactivatable antibody derivatives for pulse-chase experiments

    • FLIM-FRET approaches to study CYP75B1 protein interactions in vivo

  • Microfluidic immunoassay platforms:

    • Droplet-based microfluidics for high-throughput screening

    • Organ-on-a-chip models incorporating CYP75B1 immunodetection

    • Continuous flow immunoassays for real-time monitoring

    • Digital immunoassays for absolute quantification at low concentrations

  • Computational antibody engineering:

    • AI-driven epitope prediction for improved antibody specificity

    • In silico antibody optimization for challenging CYP75B1 epitopes

    • Structure-based antibody design utilizing CYP75B1 protein models

    • Nanobody development for enhanced penetration and accessibility

  • Novel reporter systems:

    • Split-protein complementation assays incorporating CYP75B1 antibody fragments

    • CRISPR-based endogenous tagging for native CYP75B1 visualization

    • Luciferase complementation systems for studying CYP75B1 interactions

    • Biosensor development for monitoring CYP75B1 activity in real-time

These emerging technologies will significantly enhance the precision, throughput, and scope of CYP75B1 antibody-based research in plant systems.

What are the most promising applications of CYP75B1 antibody research in plant improvement programs?

CYP75B1 antibody research holds substantial promise for advancing plant improvement programs in several key areas:

  • Stress tolerance breeding applications:

    • Use CYP75B1 antibodies as molecular markers in screening germplasm collections

    • Develop high-throughput phenotyping platforms based on CYP75B1 immunodetection

    • Implement protein-level selection criteria in breeding programs

    • Monitor CYP75B1 expression in candidate varieties during field trials

    • Focus on waterlogging tolerance traits, where CYP75B1 has shown relevance

  • Transgenic plant development and validation:

    • Use antibodies to confirm expression of engineered CYP75B1 variants

    • Assess protein localization in transgenic lines

    • Monitor protein stability and accumulation across generations

    • Evaluate post-translational modifications in engineered proteins

  • Plant adaptation mechanism analysis:

    • Study CYP75B1 expression patterns in plants adapted to extreme environments

    • Compare protein variations between domesticated crops and wild relatives

    • Assess evolutionary changes in protein structure and function

    • Identify novel CYP75B1 variants with enhanced stress response capabilities

  • Quality trait improvement applications:

    • Target flavonoid biosynthesis pathways for nutritional enhancement

    • Monitor CYP75B1 expression during fruit ripening and development

    • Correlate protein levels with desired phytonutrient profiles

    • Develop predictive models linking protein expression to quality traits

  • Precision agriculture implementations:

    • Develop field-deployable immunosensors for monitoring plant stress responses

    • Create diagnostic tools for early detection of stress conditions

    • Establish protein-based biomarkers for optimal management decisions

    • Integrate CYP75B1 data with other field parameters for comprehensive management

By applying CYP75B1 antibody research in these areas, plant scientists can accelerate the development of improved varieties with enhanced stress tolerance, particularly for waterlogging conditions where CYP75B1 has demonstrated relevance in maize and potentially other crop systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.